Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma

Overview of attention for article published in Frontiers in immunology, December 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 33,011 followers.

RT @FrontImmunol: New Research: Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma: Hepatocellular carcinom…

19 Dec 2023

Reply Repost Favourite

New Research: Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma: Hepatocellular carcinoma (HCC) is a challenging malignancy with limited treatment options beyond surgery and chemotherapy. Recent advancements… https://t.co/6

19 Dec 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.